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Multiple molecular mechanisms influence nerve regeneration. Because serine proteases were shown to affect peripheral nerve regener-
ation, we performed nerve crush experiments to study synapse reinnervation in adult mice lacking the serpin protease nexin-1 (PN-1).
PN-1 is a potent endogenous inhibitor of thrombin, trypsin, tissueplasminogenactivators (tPAs), andurokinaseplasminogenactivators.
Compared with the wild type, a significant delay in synapse reinnervation was detected in PN-1 knock-out (KO) animals, which was
associatedwith both reduced proliferation and increased apoptosis of Schwann cells. Various factors known to affect Schwann cells were
also altered. Fibrin deposits, tPA activity,mature BDNF, and the low-affinity p75 neurotrophin receptor were increased in injured sciatic
nerves of mutant mice. To test whether the absence of PN-1 in Schwann cells or in the axon caused delay in reinnervation, PN-1 was
overexpressed exclusively in the nerves of PN-1KOmice. Neuronal PN-1 expression did not rescue the delayed reinnervation. The results
suggest that Schwann cell-derived PN-1 is crucial for proper reinnervation through its contribution to the autocrine control of prolifer-
ation and survival. Thus, the precise balance between distinct proteases and serpins such as PN-1 canmodulate the overall impact on the
kinetics of recovery.
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Introduction
After nerve crush, axonal outgrowth depends on Schwann cell
guidance of the growth cone through an altered environment to
reinnervate the synaptic target. Growth cone migration is also
promoted by neurotrophic factors, cell adhesion molecules, and
extracellularmatrix (ECM) proteins (Fawcett and Keynes, 1990).
Degradation of the ECM and tissue remodeling are influenced by
the balance between serine proteases and their inhibitors. Vari-
ous studies have demonstrated the presence of plasminogen ac-
tivators (PAs) in neurons and the involvement of the PA system
in axonal outgrowth (Krystosek and Seeds, 1981, 1984). The PA
system is rapidly induced after nerve injury in sensory neurons, in
which it plays an important role in sciatic nerve transection and
regeneration (Niclou et al., 1998). Moreover, tissue PA (tPA),
urokinase (uPA), and plasminogen knock-out (KO)mice show a
delay in functional recovery after sciatic nerve crush, implying
that PAs are necessary for timely functional recovery of regener-
ating peripheral nerves (Siconolfi and Seeds, 2001a,b).
Protease nexin-1 (PN-1) is a 43 kDa protein of the serpin
superfamily (Sommer et al., 1987; Festoff et al., 1996) secreted in
the extracellular space, where it binds and inhibits several serine
proteases, including thrombin, trypsin, plasmin, tPA, and uPA
(Baker et al., 1980;Monard, 1993; Knauer et al., 2000). Its expres-
sion is finely regulated both spatially and temporally during de-
velopment and in adulthood (Mansuy et al., 1993). In vivo, PN-1
regulates proteolytic activity in both the CNS and PNS (Monard
et al., 1992; Scotti et al., 1994). PN-1 expression has also been
detected in rat aortic smooth muscle cells (Richard et al., 2004)
and mouse vessels (M. M. Lino, unpublished data). Other PN-1
sources in the peripheral nervous system are Schwann cells and
fibroblasts, whereasmicroglia andmacrophages do not express it
but take it up (D. Monard, unpublished data). Changes in PN-1
expression have been detected in various pathological states (e.g.,
Alzheimer’s disease, amyotrophic lateral sclerosis, and ictus),
suggesting that an imbalance in proteolytic activity contributes to
the pathological changes associated with these diseases (Wagner
et al., 1989; Sisodia et al., 1990; Golde et al., 1992; Vaughan et al.,
1994; Chou et al., 1998). Mechanistically, PN-1 has been shown
to promote neurite outgrowth and regulate survival or death of
injured neurons (Monard, 1988; Zurn et al., 1988; Houenou et
al., 1995; Smith-Swintosky et al., 1995; Vaughan et al., 1995;
Donovan et al., 1997). Injury of the rat sciatic nerve triggers PN-1
production in Schwann cells localized at the distal site of the
lesion (Meier et al., 1989), possibly to protect structures from
prolonged and extensive proteolytic attacks.
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The present study examined the role of PN-1 in nerve regen-
eration after sciatic nerve crush. We found a delay in reinnerva-
tion and functional recovery in PN-1 KOmice after such a lesion.
The absence of PN-1 led to formation of fibrin deposits, known to
reduce Schwann cells proliferation andmigration (Akassoglou et
al., 2002, 2003). After sciatic nerve crush, tPA activity was higher
in PN-1 KO mice than in the wild type (WT), paralleling higher
levels of mature BDNF and an increase in Schwann cell death.
Moreover, the delay in reinnervation and functional recovery
persisted in transgenic mice overexpressing PN-1 exclusively in
the nerve. These results suggest that PN-1 expression in Schwann
cells is crucial for the proper kinetics of reinnervation. They fur-
ther point to an important autocrine function of Schwann cell
PN-1 in proper reinnervation by contributing to their guidance
function.
Materials andMethods
Experimental animals. The PN-1 knock-in (KI) reporter mice, PN-1 KO,
and mice overexpressing PN-1 exclusively in neurons (PN-1 KO/Tg)
were generated as described previously (Luthi et al., 1997; Meins et al.,
2001; Kvajo et al., 2004).Mice were backcrossed for 10 generations in the
C57BL/6 line. Heterozygous mating generated PN-1 KO and wild-type
littermates. Genotyping was performed by PCR of DNA from tail biop-
sies. Wild-type C57BL/6 were purchased from Charles River (Arbresle,
France). All experimental animals were 12–16 weeks of age. All animal
experiments were approved by the Swiss veterinary authorities.
Surgery.Mice were anesthetized with a mixture of ketamine and xyla-
zine injected intraperitoneally. The right lower leg was shaved and ster-
ilized with 70% ethanol. The right sciatic nerve was exposed at the sciatic
notch. The crushwas produced by tightly compressing the sciatic nerve at
the sciatic notch with flattened forceps (Atanasoski et al., 2001, 2006a).
As opposed to a complete cut, a crush produces degeneration of distal
axons, which subsequently regenerate from the proximal segment. A
total lack of hindlimb movement together with the absence of the toe-
spreading reflex and lateral leg extension confirmed the completeness of
the nerve crush. The distal nerve stumps were recovered at 4, 7, 12, and
20 d and 2 months after the crush. Contralateral nerves were used as
unlesioned control samples.
Measurement of motor nerve conduction velocity and fibrillation poten-
tial. Conduction velocities and fibrillation potentials of the gastrocne-
mius nerve were recorded from anesthetized mice. A group of WT and
PN-1KOmice of 3 and 16weeks of age (n 3 per genotype per age) were
analyzed. A monopolar needle recording electrode was inserted into the
gastrocnemiusmuscle, and a ground electrode was placed as reference in
the opposite leg. The sciatic nerve was sectioned at the level of the hip,
and the distal stump was stimulated via a suction electrode. The com-
poundmuscle action potential in response to sciatic supramaximal stim-
ulation (0.02 ms) was recorded, and the latency between nerve stimula-
tion and the foot of the compound action potential was measured. The
nerve conduction velocity (MCV) was determined as follows: MCV 
distance between stimulating and recording electrodes/stimulus-
response latency.
Immunohistochemistry. PN-1 immunostaining was performed using
the Discovery XT automated stainer (VentanaMedical Systems, Tucson,
AZ), with DAB Map detection kit (Ventana Medical Systems). Paraffin
sections 6 m thick were used after fixation in Bouin’s fixative.
PN-1 antigen retrieval was achieved by a 96 min pretreatment in CC2
buffer (Ventana Medical Systems reagent). Slides were incubated for 1 h
at 37°C with the primary antibody: mouse anti-rat PN-1 (dilution,
1:100). They were then treated for 20 min at 37°C with Ventana Medical
Systems detection (fast red substrate) and then incubated for 20minwith
the Umap anti-Rb Multimer Alkaline Phosphatase. The signal was am-
plified using UltraMap AP XT kit (Ventana Medical Systems).
PN-1 KO, PN-1 KO/Tg, and wild-type littermate pairs were examined
histologically using sections processed under identical conditions.
Silver esterase staining was performed on fresh frozen triceps surae as
described by Frey et al. (2000). Immunohistochemistry for p75 (anti-p75
Figure 1. PN-1, nerve function and upregulation after sciatic nerve crush. A, PN-1 is ex-
pressedduringmyelination. X-gal stainingof longitudinal sections of sciatic nerves at 6 and28d
after birth is shown. PN-1 is expressed in many Schwann cells during myelination, whereas its
expression is strongly reducedwhenmyelination is almost completed.B, C, PN-1 is reexpressed
4 and 12dpc. X-gal staining of longitudinal sections of uninjured and the distal stumpof injured
sciatic nerves (B) and Hoechst staining illustrating also Schwann cell proliferation after crush
(C).D, Colabeling of BrdU and X-gal on longitudinal sections of the intact and distal stump of an
injured sciatic nerve. Arrows point to double-stained Schwann cell nuclei. Scale bars:A,B,D, 50
m.E, Immunoblot showing thepresence of PN-1protein in uninjured and4dpc sciatic nerves.
F, Electroneurogram (ENG) analysis: PN-1 deficiency does not lead to changes in gastrocnemius
nerve conduction velocity in 3-week-old and adult mice. CTR, Control. Error bars represent SD.
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was a gift from Dr. L. Reichhardt, San Francisco, CA) and fibrinogen
(sheep -human fibrinogen; United States Biological, Swampscott, MA)
was performed on fixed tissue prepared from 4% paraformaldehyde-
perfused mice using standard procedures. Fixed tissue was immersed in
30% sucrose/PBS overnight at 4°C before embedding in Tissue-Tek op-
timal cutting temperature (Sakura Finetek Europe, Zoeterwoude, Neth-
erlands) and freezing in dry ice. -Galactosidase histochemistry was per-
formed on sections from PN-1 KI mice as described previously (Kvajo et
al., 2004).
Proliferation and apoptosis. Mice were injected intraperitoneally with
bromodeoxyuridine (BrdU; 100 g/g of body weight) 2 h and 1 h before
being killed. For BrdU/S100 staining, sections were processed as de-
scribed previously (Atanasoski et al., 2004, 2006b). For S100/terminal
deoxynucleotidyl transferase (TdT)-mediated biotinylatedUTPnick end
labeling (TUNEL), longitudinal sections were fixed in 2% paraformalde-
hyde for 10 min at room temperature, blocked in PBS containing 10%
goat serum, 0.1% BSA, and 1% Triton X-100, and incubated with a
primary rabbit antiserum against S100 (1:300; Dako, Glostrup, Den-
mark) at 4°C overnight. The probes were then exposed to donkey anti-
rabbit FITC secondary antibody (1:200; Jackson ImmunoResearch,West
Grove, PA) for 60 min at room temperature. The sections were equili-
brated in TdT buffer (30 mM Trizma base, pH 7.2, 140 mM sodium
cacodylate, and 1 mM cobalt chloride) before addition of TdT and bio-
tinylated dUTP. The sections were incubated at 37°C for 90 min, and
then the reaction was stopped by incubating in 2 SSC (300mM sodium
chloride and 30 mM sodium citrate) for 10 min at room temperature.
TUNEL staining was detected by incubating the probes with strepta-
vidin–Cy3 (cyanine 3) (1:200; Jackson ImmunoResearch) for 60 min at
room temperature. Sections were mounted in AF1 (Citifluor, Canter-
bury, UK) supplemented with 4,6-diamidino-2-phenylindole (DAPI;
1:1000; Roche Diagnostics, Mannheim, Germany). Immunoreactivity
was visualized by epifluorescence microscopy and documented using a
Hamamatsu (Bridgewater, NJ) Color Chilled 3CCD Camera. Images
were processed with Adobe Photoshop 7.0 for Macintosh (Adobe Sys-
tems, San Jose, CA).
Immunoblot. Sciatic nerves were homogenized in lysis buffer (radio-
immunoprecipitation assay plus complete mixture of protease inhibi-
tors; Roche Diagnostics). Eighty micrograms of proteins were subjected
to 15% SDS-PAGE (30:1 acrylamide/bisacrylamide) and transferred to a
nitrocellulose membrane (Bio-Rad, Hercules, CA). Membranes were
blocked (PBS–0.2% Tween 20 and 5% skimmed milk) and incubated
overnight at 4°C with a mouse 4B3 anti-rat PN-1 antibody (1:1000)
(Mansuy et al., 1993) and anti-actin (1:3000; NeoMarkers, Fremont,
CA). Blots were developed using SuperSignal West Femto Maximum
Sensitivity Substrate (Pierce Biotechnology, Lausanne, Switzerland).
Histological analysis. For semithin sections and electronmicroscopy, 2
month post-sciatic nerve crush mice were anesthetized as described
above and perfused with 0.1 M phosphate buffer, pH 7.2, containing 4%
paraformaldehyde and 3% glutaraldehyde. Samples were postfixed over-
night in the same fixative at 4°C,washed in phosphate buffer, treatedwith
2% OsO4 overnight at 4°C, dehydrated in an ascending acetone series,
infiltrated with Spurr, and incubated at 60°C for polymerization. Semi-
thin sections (0.5 m) were stained with 0.1% toluidine blue and exam-
ined by electron microscopy.
Statistical analysis. For reinnervation analysis, the reinnervation rate
(total number of reinnervated synapses relative to the total number of
synapses) was counted on 10 sections through each triceps surae muscle
(on average, one of every four sections). Three to fourmice per genotype
were used for each time point. Statistical analysis was performed using
the two-tailed unpaired Student’s t test.
BrdU-positive cells were counted in two adjacent 40 objective fields,
each covering an area of 0.25mm2, 2.5–3.0mmdistal to the crush lesion.
Three animals per genotype and six sections permouse were analyzed for
a total of1000 S100-positive cells per mouse. The percentages of S100/
BrdU-positive cells were determined (mean SD) and compared using
the two-tailed unpaired Student’s t test. To quantify Schwann cell apo-
ptosis, two or more longitudinal sections of sciatic nerve were mounted
on a slide. All nuclei on the sections were counted at 40 as well as all
TUNEL-positive cells, 2.5–3.0 mm distal to the crush lesion. Three ani-
mals per genotype were analyzed, and the percentages of S100/TUNEL-
positive cells were determined (mean  SD) and compared using the
two-tailed unpaired Student’s t test.
Gel zymography. Gel zymography was performed as described previ-
ously (Lantz and Ciborowski, 1994). Mice were deeply anesthetized and
transcardially perfused with ice-cold PBS at different time points after
crush surgery. One centimeter of sciatic nerve including the crush site
and the comparable site of the contralateral uncrushed nerve were re-
moved, homogenized in 10 mM Tris-Cl, pH 6.8, and centrifuged. Dilu-
tions of the cleared homogenate (6 g of protein) and 30 g of recom-
binant tPA (Genentech, San Francisco, CA) were separated by
electrophoresis at 4°C on 10% polyacrylamide-SDS gels copolymerized
with casein (1 mg/ml; Sigma-Aldrich, Steinheim, Germany) and plas-
Figure2. Delayed axonal regeneration in the absence of PN-1.A,B, Longitudinal sections of
gastrocnemius at 4 dpc. p75 (green) and-bungarotoxin (red) double labeling indicate similar
denervation responses at NMJs. C–F, At 12 dpc, the same double labeling suggests delayed
recovery at NMJs (C,D) and at the nerves of PN-1 KOmice (E, F ).G, Silver esterase staining at 12
dpc shows delayed reinnervation in PN-1 KO NMJs (synapses, blue; nerves, black). The arrow
indicates an innervated synapse in WT, and the arrowhead indicates a denervated synapse in
KO. Scale bars: A–D (in B), G, 50m; E, F (in F ), 5m.
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minogen (2.5 U/ml; Chromogenix, Mo¨lndal, Sweden). After electro-
phoresis, the SDS was extracted from the gel using 2.5% Triton X-100,
and the gel was incubated in 0.1 M Tris, pH 8.1, at 37°C, followed by
staining with 0.125% Coomassie blue in 50%methanol/10% acetic acid.
Destaining with the same solvent revealed transparent zones of lysis
against the dark casein background at molecular weights of 65 and 43
kDa, corresponding to tPA and uPA.
Pro-BDNF and BDNF ELISA assays. Because available assays did not
distinguish between BDNF and its precursor form, a test to evaluate
pro-BDNF was first developed. The amount of pro-BDNF thus deter-
mined in a parallel assay was subtracted from the total amount of BDNF
(precursor and mature forms) measured by BDNF Emax Immunosys-
tem (Promega, Madison, WI) according to the manufacturer’s instruc-
tions to quantify the mature BDNF in samples containing 15 g of pro-
tein from crushed or intact nerves.
The pro-BDNF ELISA assay developed detected only the precursor
form of the neurotrophin. For this purpose, pro-BDNF protein pro-
duced using conditionedmedia fromCOS-7 cells transfected with furin-
resistant pro-BDNF (Fayard et al., 2005) was quantified with the BDNF
Emax Immunosystem and used as standard. After coating a 96-well plate
with mouse anti-BDNF (provided in BDNF Emax Immunosystem),
nerve lysates and 25, 50, 100, 200, and 250 pg/ml pro-BDNF standard
were added. Detection and quantification of pro-BDNF in standards and
samples were performed exactly as described for the BDNF Emax Immu-
nosystem, except that the secondary antibody was a rabbit polyclonal
anti-pro-BDNF specific for the precursor form (Millipore, Lucerne,
Switzerland).
Functional testing. Functional testing to study recovery of toe pressure
sensitivity was performed on conscious mice as described previously
(Siconolfi and Seeds, 2001b). Mice were tested every other day (n 8).
Results
PN-1 expression in Schwann cells
UsingPN-1KI reportermice,weanalyzedPN-1expressionbymon-
itoring 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-gal)
staining in nerve and muscle. PN-1 expression started 3 d after
birth (P3), increased at P6, and is almost vanished at P28 (Fig.
1A). PN-1was not expressed in the sciatic nerve of adultmice but
was strongly upregulated 4 d postcrush (dpc) (Fig. 1B–D). The
expression persisted up to 12 d after the crush (Fig. 1B,C) and
began to decrease after 20 d (data not shown). Four days after
lesion, some proliferating Schwann cells reexpressed PN-1 (Fig.
1D). This PN-1 upregulation was also detected at the protein
level (Fig. 1E). In the muscle, both in the control and after nerve
crush, PN-1 expression was detected exclusively in blood vessels
(data not shown).
Nerve conduction velocity does not differ betweenWT and
PN-1 KO mice
Myelin alteration and/or internodal distance affect the velocity of
the nerve impulse conduction (Stoffel and Bosio, 1997). Fibrilla-
tion potentials and conduction velocities in the sciatic nerves
were measured by myography and electroneurography as func-
tional tests for alterations in myelin and/or motor neurons in
PN-1 KO and WT mice. Functional innervation was ascertained
in PN-1 KO mice from the absence of fibrillation potentials in
gastrocnemius muscle. WT muscles denervated for 7 d served as
positive controls. Conduction velocity was not affected in PN-1
mutant mice, neither in 3-week-old nor in adult (3–5 months)
mice (Fig. 1F). Given that myelination is concluded at 3–4
weeks, this means that myelination developed normally in PN-1
KO mice. The absolute conduction velocities measured by our
electromyograph both in WT and mutant animals were lower
than published values (16 vs 42m/s); this is because our stimulus-
response latencies (1.5 ms) included the synaptic delay at the
neuromuscular junction (NMJ) (0.5–0.7 ms). Taking synaptic
delay into account, our velocity estimates are comparable with
those published by others (Higashimori et al., 2006).
Axonal regeneration of sciatic nerve in triceps surae is delayed
in PN-1 KO mice
The p75 low-affinity neurotrophin receptor is known to be
strongly upregulated in Schwann cells after denervation. Conse-
quently, p75 immunoreactivity was analyzed at theNMJ to inves-
tigate denervation in PN-1KOmice. As expected, prominent p75
upregulation was detected both in wild-type and KO animals 4 d
after crush (Fig. 2A,B). Twelve days after crush, p75 immunore-
activity had vanished in wild-type NMJs but was still very high in
PN-1 KO mice (Fig. 2C–F). Twenty days after crush, both KO
and wild-type muscle were negative (data not shown). Axonal
degeneration and regeneration was also confirmed by GAP-43
(growth-associated protein 43) immunohistochemistry (data not
shown).
The triceps surae muscle was analyzed by silver esterase stain-
ing to study the reinnervation rate. Four days after crush, no signs
of reinnervation were observed in either wild-type or PN-1 KO
mice (data not shown). Twelve days after crush, wild-type mice
Figure3. A, Recovery of response topinch inhindfoot digits after sciatic nerve crush.WTand
PN-1 KO mice received a pinch by forceps at the distal portion of each hindfoot digit. Vocaliza-
tion and foot withdrawal were scored as a positive response. Time (in days) to elicit an initial
response was recorded for each digit. PN-1 KOmice show a delayed recovery to pinch. Data are
mean SD values obtained from eight animals in three different experiments. *p 0.05;
two-way ANOVA. B, Immunostaining reveals increased and prolonged fibrin(ogen) deposition
in PN-1 KO mice after sciatic nerve injury. Scale bar, 100m.
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had a significantly higher reinnervation rate than PN-1 KOmice
(809.8  110 vs 148.7  61.1 synapses; *p  0.04) (Fig. 2G).
Twenty days after crush, most of the NMJs were reinnervated in
both wild-type and PN-1 KOmice (942.5 41.7 vs 970.7 87.2
synapses; p 0.05).
PN-1 KOmice show a delayed
functional recovery after sciatic
nerve crush
To further substantiate the effect of PN-1
absence on nerve regeneration, we studied
sensory and motor function recovery fol-
lowing the procedures as described previ-
ously (Devor and Govrin-Lippmann,
1979; Siconolfi and Seeds, 2001b). Before
surgery, all wild-type and mutant mice
showed equal sensitivity and response to
the test. After the crush, the responseswere
totally abolished in the injured hindlimb.
Recovery in responsiveness of the first four
digits was significantly delayed in the PN-1
KO mice (Fig. 3A). Wild-type mice could
reuse the injured leg 2–4 d earlier than the
PN-1 KO mice. On average, wild-type
mice showed a complete recovery of re-
flexes after 15 d comparedwith 18 d for the
mutantmice. These results suggest that the
absence of PN-1 delays functional recov-
ery after peripheral nerve injury.
Fibrin accumulates in PN-1 KOmice
after nerve injury
Accumulation of fibrin deposits in the sci-
atic nerve has been reported to affect
Schwann cell migration, known to be a key
issue for proper reinnervation (Akasso-
glou et al., 2002, 2003). Fibrin formation
and accumulation is mainly caused by the
cleavage of fibrinogen by thrombin
(Walsh and Ahmad, 2002), and PN-1 is a
potent thrombin inhibitor (Monard,
1993). Nerve crush was shown to induce a
time-dependent increase in thrombin ac-
tivity (Smirnova et al., 1996) and to cause
fibrin deposition (Boyd and Gordon, 2001;
Akassoglou et al., 2002). We, therefore, ex-
amined the presence of fibrin in the regener-
atingnervesofwild-typeandPN-1KOmice.
Immunostaining on longitudinal sections
revealed obviously more fibrin deposits in
PN-1 KO animals than in the wild type at all
postcrush time points (Fig. 3B).
Absence of PN-1 alters Schwann cell
proliferation and apoptosis after sciatic
nerve crush
Wenext evaluated whether the delay in re-
innervation in mice lacking PN-1 is asso-
ciated with changes in Schwann cells.
Their proliferation rate was compared in
wild-type and PN-1 KO mice 4, 12, and
20 d after lesion. Longitudinal sections of
the sciatic nerve were stained for BrdU in-
corporation, the Schwann cell marker
S100, and DAPI. The proliferation rate was determined as the
number of BrdU-positive cells relative to the total number of cells
within a defined area (0.25 mm2) (see Materials and Methods).
Compared with wild-type mice, a significant decrease in
Schwann cell proliferation rate was measured at 4 and 12 d after
Figure 4. Reduced proliferation and increased apoptosis in PN-1 KO Schwann cells. A, Longitudinal sections of uninjured and
the distal stump of crushed (12 dpc) sciatic nerves. Nerves were taken from control and PN-1 KO animals. Sciatic nerves were
double labeled with an anti-BrdU monoclonal antibody (green) and a rabbit antiserum against the Schwann cell marker S100
(red).B, Quantitative analysis of cell proliferation inWT (graybar) andPN-1KO (blackbar) sciatic nerves 4, 12, and20dpc. Data are
mean SD values obtained from three animals per time point and genotype. Significant differences are present at both 4 and 12
dpc. C, Longitudinal sections of uninjured and the distal stumpof crushed (12 dpc) sciatic nerves. Sciatic nerveswere triple labeled
with TUNEL (red), a rabbit antiserumagainst the Schwann cellmarker S100 (green), andHoechst (blue).D, Quantitative analysis
of Schwann cell apoptosis in WT (gray bar) and PN-1 KO (black bar) sciatic nerves 4, 12, and 20 dpc. Data are mean SD values
obtained from three animals per time point and genotype. Significant differences occurred at 12 dpc. Scale bars, A, C, 20m.
*p 0.05; **p 0.01; Student’s t test.
Figure 5. Myelinated peripheral nerves are maintained in the absence of PN-1. Transverse semithin sections of adult mouse
nerves stained with toluidine blue are shown. A, C, Nerve bundle of uninjured sciatic nerve of WT and PN-1 KO mice. B, D, Nerve
bundle of the distal stumpof crushednerves ofWTandPN-1KOmice 2months after sciatic nerve crush.Magnification:A,B, 20;
C, D, 40. E, F, Ultrastructure of PN-1 KO andWTmice control axons (E) and 2 months after nerve crush (F ), both at magnifica-
tions of 1400. Scale bars: A, B (in A), 20m; C, D (in C), 10m; E, F (in E), 5m.
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injury in the PN-1 KOmice ( p 0.05 and p 0.01, respectively)
(Fig. 4A,B). The apoptosis rate, determined using triple TUNEL,
S100, and DAPI staining, showed a significant increase in PN-1
KOmice 12 d after crush ( p 0.05) (Fig. 4C,D). No differences
were detected 4 and 20 d after injury.
Normal remyelination
To checkwhether the late-stage postinjury remyelination process
was affected by the absence of PN-1, histological analysis was
performed 2months after the crush. The overallmorphology and
the ultrastructure of the sciatic nerve cross sections appeared
normal in both genotypes (Fig. 5A,C,E). Both wild-type and
PN-1 KO crushed nerves showed thinner myelin sheaths than
unlesioned nerves and a similarmyelination state, indicating that
the remyelination process was ongoing (Fig. 5B,D,F).
tPA activity increases after sciatic nerve crush
Nerve injury induces a strong activation of the PA/plasminogen
system at the level of both mRNA and enzymatic activities (Si-
conolfi and Seeds, 2001a). Because PN-1 is also a potent tPA
inhibitor, tPA activity was measured in sciatic nerves before and
after injury using gel zymography. A greater increase in tPA pro-
teolytic activity was detected after nerve crush in PN-1 KO mice
at 4, 12, and 20 d after crush (Fig. 6A).
Absence of PN-1 increases the level of mature BDNF caused
by sciatic nerve crush
tPA has been implicated in the processing of pro-BDNF into
mature BDNF (Pang et al., 2004), which was reported to increase
4 d after nerve injury. The BDNF level is highest after 7 d but then
slowly decreases to normal (Marcinkiewicz et al., 1998). Because
we recorded a greater increase in tPA activity after sciatic nerve
crush in PN-1 KO than in WT mice (Fig. 6A), we evaluated the
levels of mature BDNF. Using a method distinguishing mature
BDNFs frompro-BDNF forms,mature BDNFsweremeasured in
control and crushed sciatic nerves at 4, 7, 12, and 20 d after lesion.
An increase in BDNFs was detected at 4 d after crush, with a peak
at 7 d ( p  0.0001) (Fig. 6B,C). At this stage, the levels in mice
lacking PN-1 were significantly higher than those in wild-type
animals. The levels decreased by 12 d. Interestingly, all BDNF
found in crushed sciatic nerves was in the mature form. No dif-
ferences in either total or processed BDNFwere detected in intact
nerves from wild-type or PN-1 KO animals (Fig. 6B–D).
Schwann cell-derived PN-1 regulates the kinetics
of reinnervation
To assess whether neuron-derived PN-1 is sufficient to rescue the
reinnervation delay observed in our model, we crossed PN-1 KO
mice with mice overexpressing rat PN-1 exclusively in neurons
(Meins et al., 2001). The difference in molecular weight easily
distinguished the wild type from the Thy-1 promoter-driven
transgenic protein, which is expressed in themuscle (supplemen-
tal Fig. 1A, available at www.jneurosci.org as supplemental ma-
terial) and not upregulated after lesion (data not shown).
Compared with wild-type animals, a slight, although not sta-
tistically significant, reducedreinnervationwasobservedat12dafter
crush in parental transgenic mice overexpressing PN-1 in the
wild-type background (supplemental Fig. 1B,C, available at www.
jneurosci.org as supplementalmaterial). At 12 dpc, p75 immunore-
activitywas also slightly increased, but 20d after crush, nodifference
in reinnervation could be detected (data not shown).
High expression of rat PN-1 protein level was detected in the
sciatic nerve of PN-1 KO/Tg (Fig. 7A). PN-protein expression is
Figure6. PN-1KOmice show increased tPAactivity andmatureBDNFafter sciatic nerve crush.A,
Zymography of uninjured and distal stump crush sciatic nerves 4, 12, and 20 dpc.B–D, Quantitative
analysis ofmature BDNFof uninjured anddistal stump crush sciatic nerves 4, 7, and 12dpc. Data
are mean SD values obtained from four animals per time point and genotype (BDNF deter-
minations were performed in triplicate). ***p 0.0001; one-way ANOVA. ctr, Control.
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more prominent in the nerve of the PN-1 KO/Tg than in WT.
This level, because of the constitutive activity of the Thy-1 pro-
moter, is certainly not lower than the one induced by crush in the
WT animals (Fig. 1D). Neuronal PN-1 expressed in the PN-1
KO/Tg nerve is secreted and taken up by the muscle, as detected
by immunohistochemistry (Fig. 7B). The delayed reinnervation
phenotype was still observed in progeny PN-1 KO/Tg mice 12 d
after crush (942.5 41.7 vs 278 51.4 synapses; **p 0.001), as
was the high p75 immunoreactivity (results not shown), similarly
to the changes observed in the PN-1 KOmice. Twenty days after
crush, p75 immunoreactivity had returned to normal levels, al-
though reinnervation was still reduced (data not shown). As in
PN-1 KO animals, decreased proliferation and an increased apo-
ptotic rate were detected in Schwann cells (Fig. 7C,D). The sen-
sory and motor function recovery after peripheral nerve lesion
was still delayed in these PN-1 KO/Tg mice (Fig. 7E). These data
suggest that high PN-1 expression restricted to neurons is not
sufficient to rescue the delay of reinnervation observed in PN-1
KO mice.
Discussion
The results of this study show that PN-1 deficiency slows down
the kinetics of reinnervation and the recovery of sensory and
motor functions in the hindlimb after peripheral nerve injury.
The data indicate that various factors are involved in this phe-
nomenon: reduced proliferation and increased apoptosis of
Schwann cells, increased and longer-lasting fibrin deposition,
and higher levels of mature BDNF in the nerves. Altogether, we
provide evidence that tight control of ex-
tracellular proteolytic activity is needed for
efficient reinnervation. Furthermore, be-
cause neuronal PN-1 overexpression did
not rescue the observed delay, Schwann
cell-derived PN-1 is most likely one of the
key regulatory factors for proper timing of
recovery.
Functional nerve regeneration requires
sprouting, axonal elongation, and new
myelin synthesis. The rates of dedifferen-
tiation, proliferation, and redifferentia-
tion into myelinating Schwann cells
(Kioussi and Gruss, 1996) are known to
influence the rate of nerve regeneration
(Son and Thompson, 1995a,b; Son et al.,
1996). Various factors regulate the reac-
tion to injury.
For example, the ECMmolecules of the
basal lamina are crucial for both axonal
elongation and remyelination (Bunge et
al., 1986; Reichardt and Tomaselli, 1991).
Schwann cells react to changes in the com-
position of the ECM after nerve lesion.
Among those, injury leads to accumula-
tion of fibrin associatedwith rupture of the
blood–brain barrier. Fibrin deposition
and clearing are of crucial importance for
Schwann cell migration and differentia-
tion. Inmice deficient in fibrinogen, injury
induces slow proliferating Schwann cells
with a highmyelinating potential (Akasso-
glou et al., 2002, 2003). In mice lacking
tPA, excess of fibrin exacerbates axonal de-
generation, indicating a beneficial tPA fi-
brinolytic function (Akassoglou et al.,
2000, 2002, 2003). In vitro, fibrin excess blocks Schwann cell mi-
gration, supporting observations in vivo that it prevents their
redifferentiation and myelinating function (Akassoglou et al.,
2002). In the present study, significant and sustained postinjury
fibrin deposition was also observed inmice lacking PN-1 (Fig. 3),
in which fibrin deposits persist despite the general increase in tPA
activity (Fig. 6A) (Kvajo et al., 2004). The high amount of fibrin
observed despite a higher level of tPA activitymay be explained by
the strong inhibition of thrombin by PN-1 (Baker et al., 1980;
Monard, 1993; Knauer et al., 2000), which has been shown to
increase after sciatic nerve injury (Friedmann et al., 1999;
Hirakawa et al., 2003, 2004). This suggests that generation of
fibrin overcomes the tPA fibrinolytic effect inmice lacking PN-1.
The reduced Schwann cell proliferation detected (Fig. 4A,B) ap-
pears to contradict the earlier observation that absence of fibrin
leads to a reduction in BrdU incorporation (Akassoglou et al.,
2002). Fibrin induces Schwann cells to produce p75 receptor,
which influences their apoptosis rate (Chao et al., 1998; Ferri and
Bisby, 1999; Syroid et al., 2000). Furthermore, contradictory re-
ports indicate that this receptormodulates theirmyelinating state
(Boyd and Gordon, 2001; Cosgaya et al., 2002; Tolwani et al.,
2004). In the present study, high upregulation of p75 receptor
was already detected at 4 d after crush before apoptosis was evi-
dent. It cannot, therefore, explain the decrease in proliferation
observed in the mutant mice at this stage. The influence of p75
upregulation could, however, become significant at 12 d after
crush, when a higher decrease in proliferation correlated with a
Figure7. Overexpression of PN-1 in the nerve did not rescue reinnervation delay in PN-1 KOmice.A, PN-1 sciatic nerve protein
expression inWT (1), PN-1 KO (2), and PN-1 KO/Tg (3)mice. PN-1 KO/Tgmice express a high level of rat PN-1 in the nerve.B, PN-1
immunodetection in WT, PN-1 KO, and PN-1 KO/Tg gastrocnemius muscle. Neuronal overexpressed PN-1 in PN-1 KO/Tg mice is
secreted and taken up by the muscle fibers. Scale bar, 50m. C, Quantitative analysis of cell proliferation in WT (gray bar) and
PN-1 KO/Tg (black bar) sciatic nerves at 4 and 12 dpc. Data aremean SD values obtained from three animals per time point and
genotype. Significant differences occurred at 4 and 12dpc.D, Quantitative analysis of Schwann cell apoptosis inWT (gray bar) and
PN-1 KO/Tg (black bar) sciatic nerves at 4 and 12 dpc. Data aremean SD values obtained from three animals per time point and
genotype. *p0.05; **p0.01; Student’s t test.E, Recovery of response to pinch in hindfoot digits after sciatic nerve crush.WT,
PN-1 KO, and PN-1 KO/Tg mice received a pinch to the distal portion of each hindfoot digit by forceps. Vocalization and foot
withdrawalwere noted as positive responses. Time (in days) to elicit an initial responsewas recorded for each digit. PN-1 KOmice
show a delayed response to pinch compared with WT. *p 0.05; **p 0.01; two-way ANOVA.
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significant increase in apoptosis (Fig. 4). A comparative quanti-
tative evaluation of fibrin deposition in the different studies is not
possible. However, it cannot be excluded that different levels of
fibrin accumulation could differentially affect the proliferative
response of the Schwann. Additional studies will be needed to
clarify these issues (Akassoglou et al., 2002, 2003).
Alternative mechanisms could explain an effect of PN-1 on
fine tuning of nerve regeneration. Activation of protease-
activated receptor 1 (PAR1) by thrombin perturbs neurite out-
growth and induces apoptosis and degeneration in motoneuron
cultures (Smirnova et al., 1998; Turgeon et al., 1998). PAR1 in-
creases in the proximal and distal parts of the sectioned sciatic
nerve and in denervated muscle (Niclou et al., 1998), and over-
activation of this receptor in the absence of PN-1 could conse-
quently contribute to the delayed axonal regrowth. Interestingly,
tPA, uPA, and plasminogen KO mice show delayed functional
recovery after sciatic nerve crush (Siconolfi and Seeds, 2001a,b).
Such data are in line with observations in vitro that higher levels
of tPA localize at the growth cone and contribute to its motility
(Krystosek and Seeds, 1981, 1984; Garcia-Rocha et al., 1994).
Surprisingly, our experiments gave similar results in the absence
of PN-1. Thus, removing either a protease or one of its inhibitors
leads to the same result. This seemingly contradictory situation
indicates, at least in this postlesion case, that the function of PN-1
is probably mediated by its much more potent inhibitory impact
on thrombin fibrinogenic activity. In PN-1 KO mice, the in-
creased tPA activity could lead to an increase in plasmin activity
insufficient to switch the equilibrium toward fibrin degradation
but nevertheless sufficient to enhance conversion of the BDNF
precursor to mature BDNF (Pang et al., 2004). Mature BDNF,
which increases after sciatic nerve crush (Marcinkiewicz et al.,
1998), is an important regulatory factor for correct repair after
injury (Zhang et al., 2000; Tolwani et al., 2004). It is, therefore,
interesting that higher levels of mature BDNF were detected in
mice lacking PN-1 after injury (Fig. 6). This could contribute to
the observed delayed reinnervation through various mecha-
nisms. First, mature BDNF can bind to p75, the level of which
remains high in the mutant mice, thus contributing to the apo-
ptosis (Boyd andGordon, 2001, 2002; Yeiser et al., 2004) detected
at 12 d after crush. Second, a high level of the neurotrophin can
cause direct inhibition of axonal regeneration. In fact, BDNF is
required for peripheral nerve regeneration and remyelination af-
ter injury (Sendtner et al., 1992; Zhang et al., 2000; Tolwani et al.,
2004), but its beneficial effect seems to be dose dependent, be-
cause high doses of BDNF, acting through the p75 receptor, can
significantly inhibit motor axonal regeneration (Boyd and Gor-
don, 2001, 2002). Finally, a much more speculative hypothesis
cannot be excluded. The similarity of phenotype between the
tPA, uPA, or plasminogen KOmice and the PN-1-deficient mice
could indicate that the amount of serine protease/serpin complex
formation is also involved. Because the complex between PN-1
and its target proteases has a much higher affinity to the low-
density lipoprotein receptor proteins than the individual part-
ners, one cannot exclude that this interaction could influence
distinct cellular responses (Knauer et al., 1997).
In any case, neuronal overexpressed PN-1 can be secreted by
the nerve (Fig. 7B) and is certainly more prominent in PN-1
KO/Tg than the level detected after crush in WT animals (Figs.
1D, 7A). Nevertheless, it does not rescue the observed regenera-
tion delay. This further supports the hypotheses that Schwann
cell-derived PN-1, possibly in an autocrine mechanism, is a key
regulatory factor for correct and timely recovery after injury.
In conclusion, Schwann cell-derived PN-1 is required for a nor-
mal reinnervation after sciatic nerve crush. Thus, the precise tuning
of distinct proteases via serpins such as PN-1 canmodulate different
pathways affecting the kinetics of recovery (supplemental Fig. 2,
available at www.jneurosci.org as supplemental material).
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